Mei Sheng Duh

Summary

Affiliation: Analysis Group
Country: USA

Publications

  1. ncbi request reprint The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine
    Mei Sheng Duh
    Analysis Group, Inc, Boston, Massachusetts 02199, USA
    Dis Manag 10:216-25. 2007
  2. pmc Angiogenesis inhibitor therapies for advanced renal cell carcinoma: toxicity and treatment patterns in clinical practice from a global medical chart review
    William K Oh
    Dana Farber Cancer Institute, Boston, MA, USA
    Int J Oncol 44:5-16. 2014
  3. pmc Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis
    Marie Helene Lafeuille
    Analysis Group, Inc, 111 Huntington Avenue, Tenth Floor, Boston, MA, USA
    BMC Psychiatry 13:221. 2013
  4. pmc Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study
    Marya D Zilberberg
    School of Public Health and Health Sciences, University of Massachusetts, Amherst, P, O, Box 303, Goshen, MA 01032, USA
    Crit Care 11:R63. 2007
  5. pmc Safety and treatment patterns of multikinase inhibitors in patients with metastatic renal cell carcinoma at a tertiary oncology center in Italy
    Camillo Porta
    Medical Oncology, I R C C S San Matteo University Hospital Foundation, Piazzale C, Golgi 19, 27100 Pavia, Italy
    BMC Cancer 11:105. 2011
  6. doi request reprint The risks and costs of multiple-generic substitution of topiramate
    M S Duh
    Analysis Group, Inc, Boston, MA 02199, USA
    Neurology 72:2122-9. 2009
  7. doi request reprint Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis
    Mei Sheng Duh
    Analysis Group, Inc, Boston, MA 02199, USA
    Curr Med Res Opin 25:2081-90. 2009
  8. ncbi request reprint Impact of compliance with proton pump inhibitors on NSAID treatment
    Mei Sheng Duh
    Analysis Group, Inc, Boston, MA 02199, USA
    Am J Manag Care 15:681-8. 2009
  9. doi request reprint The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence
    Mei Sheng Duh
    Analysis Group, Inc, 111 Huntington Avenue, Tenth Floor, Boston, MA 02199, USA
    Expert Opin Pharmacother 10:2317-28. 2009
  10. ncbi request reprint Anaemia and the risk of injurious falls in a community-dwelling elderly population
    Mei Sheng Duh
    Analysis Group, Inc, Boston, Massachusetts 02199, USA
    Drugs Aging 25:325-34. 2008

Collaborators

Detail Information

Publications48

  1. ncbi request reprint The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine
    Mei Sheng Duh
    Analysis Group, Inc, Boston, Massachusetts 02199, USA
    Dis Manag 10:216-25. 2007
    ..Payers may weigh smaller-than-expected cost reductions against a possible decrease in effectiveness to assess the relevance of mandatory generic switching of lamotrigine...
  2. pmc Angiogenesis inhibitor therapies for advanced renal cell carcinoma: toxicity and treatment patterns in clinical practice from a global medical chart review
    William K Oh
    Dana Farber Cancer Institute, Boston, MA, USA
    Int J Oncol 44:5-16. 2014
    ..Findings suggest an unmet need for more tolerable agents for RCC treatment...
  3. pmc Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis
    Marie Helene Lafeuille
    Analysis Group, Inc, 111 Huntington Avenue, Tenth Floor, Boston, MA, USA
    BMC Psychiatry 13:221. 2013
    ....
  4. pmc Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study
    Marya D Zilberberg
    School of Public Health and Health Sciences, University of Massachusetts, Amherst, P, O, Box 303, Goshen, MA 01032, USA
    Crit Care 11:R63. 2007
    ..Uncertainty remains regarding the strength of this relationship...
  5. pmc Safety and treatment patterns of multikinase inhibitors in patients with metastatic renal cell carcinoma at a tertiary oncology center in Italy
    Camillo Porta
    Medical Oncology, I R C C S San Matteo University Hospital Foundation, Piazzale C, Golgi 19, 27100 Pavia, Italy
    BMC Cancer 11:105. 2011
    ..This study assessed safety and treatment patterns for these agents in a real-world clinical practice setting in Italy...
  6. doi request reprint The risks and costs of multiple-generic substitution of topiramate
    M S Duh
    Analysis Group, Inc, Boston, MA 02199, USA
    Neurology 72:2122-9. 2009
    ..To investigate clinical and economic consequences following generic substitution of one vs multiple generics of topiramate (Topamax; Ortho-McNeil Neurologics, Titusville, NJ)...
  7. doi request reprint Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis
    Mei Sheng Duh
    Analysis Group, Inc, Boston, MA 02199, USA
    Curr Med Res Opin 25:2081-90. 2009
    ..This study evaluated the incremental costs associated with IV administration of selected AI therapies (bevacizumab off-label) compared to oral therapies (sunitinib or sorafenib) for the treatment of RCC...
  8. ncbi request reprint Impact of compliance with proton pump inhibitors on NSAID treatment
    Mei Sheng Duh
    Analysis Group, Inc, Boston, MA 02199, USA
    Am J Manag Care 15:681-8. 2009
    ....
  9. doi request reprint The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence
    Mei Sheng Duh
    Analysis Group, Inc, 111 Huntington Avenue, Tenth Floor, Boston, MA 02199, USA
    Expert Opin Pharmacother 10:2317-28. 2009
    ..The American Academy of Neurology (AAN) disagrees and opposes generic substitution of branded antiepileptic drugs (AEDs) without physician and patient approval due to the risk of loss of seizure control...
  10. ncbi request reprint Anaemia and the risk of injurious falls in a community-dwelling elderly population
    Mei Sheng Duh
    Analysis Group, Inc, Boston, Massachusetts 02199, USA
    Drugs Aging 25:325-34. 2008
    ..These may contribute to falls which, in the elderly, result in serious injuries in perhaps 10% of cases...
  11. ncbi request reprint Costs associated with intravenous chemotherapy administration in patients with small cell lung cancer: a retrospective claims database analysis
    Mei Sheng Duh
    Analysis Group, Inc, Boston, MA 02199, USA
    Curr Med Res Opin 24:967-74. 2008
    ..This study aims to assess costs associated with IV chemotherapy in patients with small cell lung cancer (SCLC) from the perspective of large employer-payers...
  12. doi request reprint The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease
    Antoine Gosselin
    Analysis Group, Inc, Boston, MA 02199, USA
    Value Health 12:34-9. 2009
    ..This study examined the effect of GERD patients' compliance with PPI therapy on health-care resource utilization and costs...
  13. ncbi request reprint Management of anaemia: a critical and systematic review of the cost effectiveness of erythropoiesis-stimulating agents
    Mei Sheng Duh
    Analysis Group, Inc, Boston, Massachusetts 02199, USA
    Pharmacoeconomics 26:99-120. 2008
    ....
  14. ncbi request reprint Impact and treatment of anemia in the elderly: clinical, epidemiological and economic perspectives
    Mei Sheng Duh
    Analysis Group, Inc, 111 Huntington Avenue, Tenth Floor, Boston, MA 02199, USA
    Expert Rev Pharmacoecon Outcomes Res 6:577-90. 2006
    ..g., cancer/chemotherapy and chronic kidney disease). Evidence that highlights the benefits of erythropoietic therapies and their use in the treatment of anemia of chronic disease in the elderly is reviewed in this article...
  15. ncbi request reprint The cost-effectiveness of weekly epoetin alfa relative to weekly darbepoetin alfa in patients with chemotherapy-induced anemia
    R Ben-Hamadi
    Analysis Group, Inc Boston, MA 02199, USA
    Curr Med Res Opin 21:1677-82. 2005
    ..25 U once weekly and DARB 2.25 mcg/kg once weekly)...
  16. ncbi request reprint Assessing the clinical benefits of erythropoietic agents using area under the hemoglobin change curve
    Mei Sheng Duh
    Analysis Group, Inc, 111 Huntington Avenue, Tenth Floor, Boston, Massachusetts 02199, USA
    Oncologist 10:438-48. 2005
    ..Area under the hemoglobin change curve (Hb AUC) is introduced as an alternative measure, and its reliability, clinical significance, and superiority are assessed...
  17. ncbi request reprint Dosing patterns and costs of erythropoietic agents in patients with chronic kidney disease not on dialysis in managed care organizations
    Mei Sheng Duh
    Analysis Group, Inc, Boston, Massachusetts 02199, USA
    Clin Ther 28:1443-50. 2006
    ..Epoetin alfa (EPO) and darbepoetin alfa (DARB) are erythropoietic agents indicated in the United States for the treatment of anemia in chronic kidney disease (CKD)...
  18. ncbi request reprint Dosing patterns and treatment costs of erythropoietic agents in elderly patients with pre-dialysis chronic kidney disease in managed care organisations
    Mei Sheng Duh
    Analysis Group Inc, Boston, Massachusetts 02199, USA
    Drugs Aging 23:969-76. 2006
    ....
  19. doi request reprint Risk of hepatotoxicity-related hospitalizations among patients treated with opioid/acetaminophen combination prescription pain medications
    Mei Sheng Duh
    Analysis Group, Inc, Boston, Massachusetts 02199, USA
    Pain Med 11:1718-25. 2010
    ..This study determined the risk of serious hepatotoxicity resulting in hospitalizations among patients prescribed opioid/acetaminophen combinations...
  20. ncbi request reprint Dose and cost comparison of erythropoietic agents in the inpatient hospital setting
    Francis Vekeman
    Analysis Group, Inc, Montreal, Quebec, Canada
    Am J Health Syst Pharm 64:1943-9. 2007
    ..The inpatient dosing patterns and treatment costs in cancer and predialysis chronic kidney disease (CKD) patients treated with erythropoietic agents from a hospital pharmacy perspective were studied...
  21. doi request reprint The economic impact of pre-dialysis epoetin alpha on health care and work loss costs in chronic kidney disease: an employer's perspective
    Erick Moyneur
    Analysis Group, Boston, Massachusetts 02199, USA
    Dis Manag 11:49-58. 2008
    ..0267, in multivariate regression). In conclusion, anemic CKD patients treated with EPO before dialysis had significantly lower direct and indirect costs compared to non-EST-treated patients...
  22. ncbi request reprint Benefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemia
    Susana M Campos
    Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Natl Compr Canc Netw 3:807-16. 2005
    ..Early hemoglobin response may therefore be considered as a desired goal of epoetin alfa therapies...
  23. doi request reprint Symptom assessment in relapsed small cell lung cancer: cross-validation of the patient symptom assessment in lung cancer instrument
    Lei Chen
    Analysis Group, Inc, Boston, Massachusetts, USA
    J Thorac Oncol 3:1137-45. 2008
    ..This study cross-validates the PSALC using oral topotecan (OT) trial data...
  24. ncbi request reprint Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease
    Mari Nakabayashi
    Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA
    Cancer 119:2990-8. 2013
    ..This study sought to characterize Modern patients with castration-resistant prostate cancer (CRPC) and identify pretreatment clinical predictors of survival...
  25. doi request reprint The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review
    Edmond L Toy
    Analysis Group, Inc, Lakewood, Colorado, USA
    COPD 7:214-28. 2010
    ..Evaluation of pharmacoeconomic analyses would be aided by the use of more consistent and comprehensive approaches to defining and measuring COPD exacerbations...
  26. doi request reprint Safety and treatment patterns of angiogenesis inhibitors in patients with metastatic renal cell carcinoma: evidence from US community oncology clinics
    Bruce A Feinberg
    Cardinal Health, Inc, Dublin, OH, USA
    Med Oncol 29:786-94. 2012
    ..Rates of treatment modifications due to AEs tended to be higher in community practice. This study provides evidence from an office-based setting of unmet need for agents that may provide improved tolerability in mRCC...
  27. pmc Evaluating the utility of existing patient-reported outcome scales in novel patient populations with pancreatic cancer, lung cancer, and myeloproliferative neoplasms using medicare current beneficiary survey data
    Jasmina I Ivanova
    Analysis Group, Inc, New York, NY, USA
    Patient 6:189-200. 2013
    ....
  28. ncbi request reprint Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice-based on medical chart review
    Toni K Choueiri
    Dana Farber Cancer Institute, Boston, MA, USA
    BJU Int 105:1247-54. 2010
    ..To assess the effectiveness, safety, and treatment patterns of anti-angiogenic agents in metastatic renal cell carcinoma (mRCC) in tertiary clinical practice settings...
  29. doi request reprint Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs
    Edmond L Toy
    Analysis Group, Inc, 225 Union Blvd, Suite 600, Lakewood, CO 80228, USA
    Respir Med 105:435-41. 2011
    ..Medication adherence is important in managing COPD. This study analyzed real-world use of inhaled medications for COPD to characterize relationships between daily dosing frequency, adherence, healthcare resource utilization, and cost...
  30. ncbi request reprint Psychometric validation of the Patient Symptom Assessment in Lung Cancer instrument for small cell lung cancer
    Lei Chen
    Analysis Group, Inc, Boston, MA 02199, USA
    Curr Med Res Opin 23:2741-52. 2007
    ..This study aims to retrospectively evaluate the psychometric properties of PSALC using clinical trial data...
  31. doi request reprint Costs, quality of life and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature
    Jennifer R Weiner
    Analysis Group, Inc, 111 Huntington Avenue, Tenth Floor, Boston, MA 02199, USA
    Expert Opin Pharmacother 9:751-66. 2008
    ..Cystic fibrosis is the most common incurable hereditary disease in the US. Persistent respiratory infection is the leading cause of morbidity and mortality in cystic fibrosis patients...
  32. ncbi request reprint Costs associated with cardiovascular events in patients with hypertension in US managed care settings
    Mei Sheng Duh
    Analysis Group, Inc, Boston, Massachusetts, USA
    J Am Soc Hypertens 3:403-15. 2009
    ..First-quarter post-event costs were attributable to inpatient costs. CV events are costly sequelae of hypertension in high-risk and CI subgroups...
  33. ncbi request reprint The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid
    William K Oh
    Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 109:1090-6. 2007
    ..For this observational study, the authors assessed the risk of renal impairment in patients with HRPC who received zoledronic acid from December 1999 to April 2005...
  34. ncbi request reprint Systematic literature review of the costs of pregnancy in the US
    Lynn Huynh
    Analysis Group, Inc, 111 Huntington Avenue, Tenth Floor, Boston, MA, 02199, USA
    Pharmacoeconomics 31:1005-30. 2013
    ..The cost of pregnancy is increasing over time despite the decline in pregnancy rates...
  35. ncbi request reprint Algorithms to identify colonic ischemia, complications of constipation and irritable bowel syndrome in medical claims data: development and validation
    Bruce E Sands
    Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
    Pharmacoepidemiol Drug Saf 15:47-56. 2006
    ..This report describes the development and validation of claims-based algorithms to identify colonic ischemia, hospitalized complications of constipation, and irritable bowel syndrome (IBS)...
  36. ncbi request reprint Alkaline phosphatase predicts survival in patients with metastatic neuroendocrine tumors
    Thomas E Clancy
    Department of Surgery, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Dig Dis Sci 51:877-84. 2006
    ..Close monitoring of alkaline phosphatase levels may be useful when considering initiation or changes of therapy in patients with metastatic neuroendocrine tumors...
  37. ncbi request reprint Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations
    Patrick Lefebvre
    Groupe d Analyse, Ltee, Montreal, Quebec, Canada
    Curr Med Res Opin 22:1623-31. 2006
    ..To investigate the dosing patterns and treatment costs of erythropoietic agents in adult (>or= 18 years of age) cancer patients newly initiated on epoetin alfa (EPO) or darbepoetin alfa (DARB) in managed care organizations...
  38. ncbi request reprint Medical costs of untreated anemia in elderly patients with predialysis chronic kidney disease
    Patrick Lefebvre
    Groupe d Analyse, Montreal, Quebec, Canada
    J Am Soc Nephrol 17:3497-502. 2006
    ..This large study, which was based on real-life practice data, demonstrated that untreated anemia in elderly patients with predialysis CKD was associated with a significant increase in medical costs...
  39. ncbi request reprint The economic impact of epoetin alfa therapy on delaying time to dialysis in elderly patients with chronic kidney disease
    Patrick Lefebvre
    Groupe d Analyse, Ltee, Montreal, Quebec, Canada
    Dis Manag 10:37-45. 2007
    ..This retrospective matched cohort study suggests that EPO therapy has a beneficial impact on delaying progression to dialysis in elderly CKD patients, especially in those with less severe CKD...
  40. ncbi request reprint Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes
    Frederick Andermann
    Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada
    Epilepsia 48:464-9. 2007
    ....
  41. ncbi request reprint Is there a difference in the cost-effectiveness of erythropoietic therapies for the treatment of anemia in patients receiving HCV combination therapy?
    Wenchen Kenneth Wu
    Hepatology 46:283; author reply 283-4. 2007
  42. ncbi request reprint Cost analytic model to determine the least costly inpatient erythropoiesis stimulating therapy regimen
    Harminder Sikand
    Scripps Mercy Hospital, Cardinal Health, San Diego, CA, USA
    Ann Pharmacother 42:16-23. 2008
    ..Unlike in outpatient settings, the comparative costs of epoetin alpha (EPO) and darbepoetin alpha (DARB) have not been evaluated broadly from the inpatient hospital perspective...
  43. ncbi request reprint Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting
    Jacques Lelorier
    Centre de Recherche, Centre Hospitalier de l Universite de Montreal, Quebec, Canada
    Curr Med Res Opin 24:1069-81. 2008
    ..Generic substitution may not always save health care costs for antiepileptic drugs (AED)...
  44. doi request reprint Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysis
    Victor Moyo
    Ortho Biotech Clinical Affairs, LLC, Bridgewater, NJ, USA
    Ann Hematol 87:527-36. 2008
    ..With the use of standardized patient selection and response evaluation methods, epoetin alfa and darbepoetin alfa yielded comparable erythroid response rates in MDS patients...
  45. ncbi request reprint A survey-based assessment of the prevalence and severity of chronic hand dermatitis in a managed care organization
    Joseph F Fowler
    University of Louisville, Kentucky, USA
    Cutis 77:385-92. 2006
    ..Approximately 1 in 6 members did not seek medical attention, suggesting that chronic hand dermatitis may be underdetected and untreated and may require more awareness and effective management...
  46. ncbi request reprint Risk of cancer treatment-associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors
    Betty A Mincey
    Mayo Clinic, Jacksonville, FL, USA
    Clin Breast Cancer 7:127-32. 2006
    ..However, AIs can cause bone loss by blocking estrogen production. This study aims to assess the association between AIs and treatment-related bone loss in a large managed-care population of women with breast cancer...
  47. ncbi request reprint The direct and indirect cost burden of atopic dermatitis: an employer-payer perspective
    Joseph F Fowler
    Division of Dermatology, University of Louisville, Kentucky, USA
    Manag Care Interface 20:26-32. 2007
    ..001; indirect: $31, P< .001). Employer-payers experience a significant annual cost burden of $991 per patient attributable to AD. Employee disability and increased sick days account for 38% of the cost burden...